APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alinia (nitazoxanide)

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Selected research

Market Outlook & Growth Opportunities

Global Alinia (nitazoxanide) Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchAlinia (nitazoxanide) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Alinia (nitazoxanide) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Alinia (nitazoxanide) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alinia (nitazoxanide) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alinia (nitazoxanide) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.

This report provides an overview of the global Alinia (nitazoxanide) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Alinia (nitazoxanide) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alinia (nitazoxanide) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alinia (nitazoxanide) market size, projected growth trends, production technologies, key applications, and end-use industries.

Alinia (nitazoxanide) Segment by Company

Romark Laboratories

Chugai Pharmaceutical

Lupin

Alinia (nitazoxanide) Segment by Type

Tablets

Oral Suspension

Alinia (nitazoxanide) Segment by Application

Retail Pharmacy

Hospital

Others

Alinia (nitazoxanide) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Alinia (nitazoxanide) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alinia (nitazoxanide) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alinia (nitazoxanide) significant trends, drivers, influence factors in global and regions.

6. To analyze Alinia (nitazoxanide) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alinia (nitazoxanide) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alinia (nitazoxanide) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alinia (nitazoxanide).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alinia (nitazoxanide) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alinia (nitazoxanide) industry.

Chapter 3: Detailed analysis of Alinia (nitazoxanide) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alinia (nitazoxanide) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alinia (nitazoxanide) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alinia (nitazoxanide) Industry Trends Table 2. Alinia (nitazoxanide) Industry Drivers Table 3. Alinia (nitazoxanide) Industry Opportunities and Challenges Table 4. Alinia (nitazoxanide) Industry Restraints Table 5. Global Alinia (nitazoxanide) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alinia (nitazoxanide) Revenue Share by Company (2021-2026) Table 7. Global Alinia (nitazoxanide) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Alinia (nitazoxanide) Sales Volume Share by Company (2021-2026) Table 9. Global Alinia (nitazoxanide) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Alinia (nitazoxanide) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alinia (nitazoxanide) Key Company Manufacturing Base & Headquarters Table 12. Global Alinia (nitazoxanide) Company, Product Type & Application Table 13. Global Alinia (nitazoxanide) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alinia (nitazoxanide) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Oral Suspension Table 19. Global Alinia (nitazoxanide) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Alinia (nitazoxanide) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Alinia (nitazoxanide) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Alinia (nitazoxanide) Sales Volume Share by Type (2021-2026) Table 23. Global Alinia (nitazoxanide) Sales Volume Share by Type (2027-2032) Table 24. Global Alinia (nitazoxanide) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Alinia (nitazoxanide) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Alinia (nitazoxanide) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Alinia (nitazoxanide) Sales Value Share by Type (2021-2026) Table 28. Global Alinia (nitazoxanide) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Hospital Table 31. Significant Companies of Others Table 32. Global Alinia (nitazoxanide) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Alinia (nitazoxanide) Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Alinia (nitazoxanide) Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Alinia (nitazoxanide) Sales Volume Share by Application (2021-2026) Table 36. Global Alinia (nitazoxanide) Sales Volume Share by Application (2027-2032) Table 37. Global Alinia (nitazoxanide) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Alinia (nitazoxanide) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Alinia (nitazoxanide) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Alinia (nitazoxanide) Sales Value Share by Application (2021-2026) Table 41. Global Alinia (nitazoxanide) Sales Value Share by Application (2027-2032) Table 42. Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Alinia (nitazoxanide) Sales by Region (2021-2026) & (K Units) Table 44. Global Alinia (nitazoxanide) Sales Market Share by Region (2021-2026) Table 45. Global Alinia (nitazoxanide) Sales by Region (2027-2032) & (K Units) Table 46. Global Alinia (nitazoxanide) Sales Market Share by Region (2027-2032) Table 47. Global Alinia (nitazoxanide) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Alinia (nitazoxanide) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Alinia (nitazoxanide) Sales Value Share by Region (2021-2026) Table 50. Global Alinia (nitazoxanide) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Alinia (nitazoxanide) Sales Value Share by Region (2027-2032) Table 52. Global Alinia (nitazoxanide) Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Alinia (nitazoxanide) Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Alinia (nitazoxanide) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 57. Global Alinia (nitazoxanide) Sales Market Share by Country (2021-2026) Table 58. Global Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 59. Global Alinia (nitazoxanide) Sales Market Share by Country (2027-2032) Table 60. Global Alinia (nitazoxanide) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Alinia (nitazoxanide) Sales Value Market Share by Country (2021-2026) Table 62. Global Alinia (nitazoxanide) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Alinia (nitazoxanide) Sales Value Market Share by Country (2027-2032) Table 64. Romark Laboratories Company Information Table 65. Romark Laboratories Business Overview Table 66. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Romark Laboratories Alinia (nitazoxanide) Product Portfolio Table 68. Romark Laboratories Recent Development Table 69. Chugai Pharmaceutical Company Information Table 70. Chugai Pharmaceutical Business Overview Table 71. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio Table 73. Chugai Pharmaceutical Recent Development Table 74. Lupin Company Information Table 75. Lupin Business Overview Table 76. Lupin Alinia (nitazoxanide) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lupin Alinia (nitazoxanide) Product Portfolio Table 78. Lupin Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Alinia (nitazoxanide) Distributors List Table 82. Alinia (nitazoxanide) Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Alinia (nitazoxanide) Product Image Figure 2. Global Alinia (nitazoxanide) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alinia (nitazoxanide) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alinia (nitazoxanide) Sales (2021-2032) & (K Units) Figure 5. Global Alinia (nitazoxanide) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Alinia (nitazoxanide) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Oral Suspension Image Figure 11. Global Alinia (nitazoxanide) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Alinia (nitazoxanide) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Alinia (nitazoxanide) Sales Volume Share by Type (2021-2032) Figure 14. Global Alinia (nitazoxanide) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Alinia (nitazoxanide) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Alinia (nitazoxanide) Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Hospital Image Figure 19. Others Image Figure 20. Global Alinia (nitazoxanide) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Alinia (nitazoxanide) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Alinia (nitazoxanide) Sales Volume Share by Application (2021-2032) Figure 23. Global Alinia (nitazoxanide) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Alinia (nitazoxanide) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Alinia (nitazoxanide) Sales Value Share by Application (2021-2032) Figure 26. Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Alinia (nitazoxanide) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Alinia (nitazoxanide) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Alinia (nitazoxanide) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Alinia (nitazoxanide) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Alinia (nitazoxanide) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Alinia (nitazoxanide) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Alinia (nitazoxanide) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Alinia (nitazoxanide) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Alinia (nitazoxanide) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Alinia (nitazoxanide) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Alinia (nitazoxanide) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Alinia (nitazoxanide) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Alinia (nitazoxanide) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Alinia (nitazoxanide) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Alinia (nitazoxanide) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Suspension
Applications
  • Retail Pharmacy
  • Hospital
  • Others
Companies covered
  • Romark Laboratories
  • Chugai Pharmaceutical
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alinia (nitazoxanide) Sales Value (2021-2032)
  4. 1.2.2 Global Alinia (nitazoxanide) Sales Volume (2021-2032)
  5. 1.2.3 Global Alinia (nitazoxanide) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alinia (nitazoxanide) Market Dynamics
  1. 2.1 Alinia (nitazoxanide) Industry Trends
  2. 2.2 Alinia (nitazoxanide) Industry Drivers
  3. 2.3 Alinia (nitazoxanide) Industry Opportunities and Challenges
  4. 2.4 Alinia (nitazoxanide) Industry Restraints
3 Alinia (nitazoxanide) Market by Company
  1. 3.1 Global Alinia (nitazoxanide) Company Revenue Ranking in 2025
  2. 3.2 Global Alinia (nitazoxanide) Revenue by Company (2021-2026)
  3. 3.3 Global Alinia (nitazoxanide) Sales Volume by Company (2021-2026)
  4. 3.4 Global Alinia (nitazoxanide) Average Price by Company (2021-2026)
  5. 3.5 Global Alinia (nitazoxanide) Company Ranking (2024-2026)
  6. 3.6 Global Alinia (nitazoxanide) Company Manufacturing Base and Headquarters
  7. 3.7 Global Alinia (nitazoxanide) Company Product Type and Application
  8. 3.8 Global Alinia (nitazoxanide) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alinia (nitazoxanide) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alinia (nitazoxanide) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alinia (nitazoxanide) Market by Type
  1. 4.1 Alinia (nitazoxanide) Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Oral Suspension
  4. 4.2 Global Alinia (nitazoxanide) Sales Volume by Type
  5. 4.2.1 Global Alinia (nitazoxanide) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alinia (nitazoxanide) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Alinia (nitazoxanide) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Alinia (nitazoxanide) Sales Value by Type
  9. 4.3.1 Global Alinia (nitazoxanide) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alinia (nitazoxanide) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Alinia (nitazoxanide) Sales Value Share by Type (2021-2032)
5 Alinia (nitazoxanide) Market by Application
  1. 5.1 Alinia (nitazoxanide) Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Alinia (nitazoxanide) Sales Volume by Application
  6. 5.2.1 Global Alinia (nitazoxanide) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alinia (nitazoxanide) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Alinia (nitazoxanide) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Alinia (nitazoxanide) Sales Value by Application
  10. 5.3.1 Global Alinia (nitazoxanide) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Alinia (nitazoxanide) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Alinia (nitazoxanide) Sales Value Share by Application (2021-2032)
6 Alinia (nitazoxanide) Regional Sales and Value Analysis
  1. 6.1 Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alinia (nitazoxanide) Sales by Region (2021-2032)
  3. 6.2.1 Global Alinia (nitazoxanide) Sales by Region: 2021-2026
  4. 6.2.2 Global Alinia (nitazoxanide) Sales by Region (2027-2032)
  5. 6.3 Global Alinia (nitazoxanide) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alinia (nitazoxanide) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alinia (nitazoxanide) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alinia (nitazoxanide) Sales Value by Region (2027-2032)
  9. 6.5 Global Alinia (nitazoxanide) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alinia (nitazoxanide) Sales Value (2021-2032)
  12. 6.6.2 North America Alinia (nitazoxanide) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alinia (nitazoxanide) Sales Value (2021-2032)
  15. 6.7.2 Europe Alinia (nitazoxanide) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alinia (nitazoxanide) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alinia (nitazoxanide) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alinia (nitazoxanide) Sales Value (2021-2032)
  21. 6.9.2 South America Alinia (nitazoxanide) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alinia (nitazoxanide) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alinia (nitazoxanide) Sales Value Share by Country, 2025 VS 2032
7 Alinia (nitazoxanide) Country-level Sales and Value Analysis
  1. 7.1 Global Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alinia (nitazoxanide) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alinia (nitazoxanide) Sales by Country (2021-2032)
  4. 7.3.1 Global Alinia (nitazoxanide) Sales by Country (2021-2026)
  5. 7.3.2 Global Alinia (nitazoxanide) Sales by Country (2027-2032)
  6. 7.4 Global Alinia (nitazoxanide) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alinia (nitazoxanide) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alinia (nitazoxanide) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alinia (nitazoxanide) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alinia (nitazoxanide) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alinia (nitazoxanide) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Romark Laboratories
  2. 8.1.1 Romark Laboratories Company Information
  3. 8.1.2 Romark Laboratories Business Overview
  4. 8.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
  6. 8.1.5 Romark Laboratories Recent Developments
  7. 8.2 Chugai Pharmaceutical
  8. 8.2.1 Chugai Pharmaceutical Company Information
  9. 8.2.2 Chugai Pharmaceutical Business Overview
  10. 8.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
  12. 8.2.5 Chugai Pharmaceutical Recent Developments
  13. 8.3 Lupin
  14. 8.3.1 Lupin Company Information
  15. 8.3.2 Lupin Business Overview
  16. 8.3.3 Lupin Alinia (nitazoxanide) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
  18. 8.3.5 Lupin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alinia (nitazoxanide) Value Chain Analysis
  2. 9.1.1 Alinia (nitazoxanide) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alinia (nitazoxanide) Sales Mode & Process
  6. 9.2 Alinia (nitazoxanide) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alinia (nitazoxanide) Distributors
  9. 9.2.3 Alinia (nitazoxanide) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst